期刊
JOURNAL OF THORACIC ONCOLOGY
卷 12, 期 1, 页码 S1302-S1303出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2016.11.1841
关键词
atezolizumab; NSCLC; Immunotherapy; Erlotinib